NYSE: TRLV
Trulieve Cannabis Corp Stock

$11.50
Updated Jun 10, 2026
TRLV Price
$11.50
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$11.00
52 Week High
$12.30
P/E
-27.38x
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$1.17B
Earnings
-$81.11M
Gross Margin
59.7%
Operating Margin
13.41%
Profit Margin
-6.9%
Debt to Equity
1.4
Operating Cash Flow
$278M
Beta
-1.05
Next Earnings
Aug 6, 2026
Ex-Dividend
N/A
Next Dividend
N/A

TRLV Overview

Trulieve Cannabis Corporation, along with its various subsidiaries, functions as a prominent medical marijuana enterprise. This company manages the entire production cycle, from cultivating its own cannabis to manufacturing finished goods in-house. Its products are then distributed directly to consumers through Trulieve-branded dispensaries located in Florida, with the added convenience of home delivery services within the state. Trulieve boasts a wide array of cannabis product types, including traditional flower, edibles, vaporizer cartridges, concentrates, topical applications, capsules, tinctures, dissolvable powders, and even nasal sprays. These are offered under several proprietary brands, such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One. As of March 16, 2022, the company's retail presence included 162 dispensaries across multiple states. This network comprised 113 stores in Florida, 19 affiliated locations in Pennsylvania, 17 in Arizona, 5 in California, 3 in Maryland, 2 each in Massachusetts and West Virginia, and one in Connecticut. Beyond retail, Trulieve Cannabis Corp. also operates cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. Tracing its origins back to an incorporation in 1940, the company was initially known as Schyan Exploration Inc./Exploration Schyan Inc. It officially adopted the name Trulieve Cannabis Corp. in September 2018 and maintains its headquarters in Quincy, Florida.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine TRLV's potential to beat the market

AStrong Buy
  • Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Be the first to know about important TRLV news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TRLV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TRLV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TRLV is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
TRLV's Earnings (EBIT) of $156.88M... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more TRLV due diligence checks available for Premium users.

Valuation

TRLV price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-27.38x
Industry
0x
Market
14.77x

TRLV's financial health

Profit margin

Revenue
$286.8M
Net Income
$2.4M
Profit Margin
0.8%
TRLV's Earnings (EBIT) of $156.88M... subscribe to Premium to read more.
Interest Coverage Financials
TRLV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.8B
Liabilities
$1.6B
Debt to equity
1.4
TRLV's short-term assets ($652.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TRLV's long-term liabilities ($1.51B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TRLV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
TRLV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$55.7M
Investing
-$13.2M
Financing
$54.8M
TRLV's operating cash flow ($277.79M)... subscribe to Premium to read more.
Debt Coverage Financials

Trulieve Cannabis Stock FAQ

What is Trulieve Cannabis's quote symbol?

(NYSE: TRLV) Trulieve Cannabis trades on the NYSE under the ticker symbol TRLV. Trulieve Cannabis stock quotes can also be displayed as NYSE: TRLV.

If you're new to stock investing, here's how to buy Trulieve Cannabis stock.

What is the 52 week high and low for Trulieve Cannabis (NYSE: TRLV)?

(NYSE: TRLV) Trulieve Cannabis's 52-week high was $12.30, and its 52-week low was $11.00. It is currently -6.5% from its 52-week high and 4.55% from its 52-week low.

How much is Trulieve Cannabis's stock price per share?

(NYSE: TRLV) Trulieve Cannabis stock price per share is $11.50 today (as of Jun 10, 2026).

How much is Trulieve Cannabis stock worth today?

Trulieve Cannabis stock was originally listed at a price of $10.51 in Sep 27, 2018. If you had invested in Trulieve Cannabis stock at $10.51, your return over the last 7 years would have been 9.45%, for an annualized return of 1.3% (not including any dividends or dividend reinvestments).
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.